Prediagnostic plasma vitamin B6 (pyridoxal 5′-phosphate) and survival in patients with colorectal cancer

Cancer Causes and Control

Volumn 24, Issue 4, 2013, Pages 719-729

  Je, Youjin ^a   Lee, Jung Eun ^c   Ma, Jing ^d   Zhang, Xuehong ^d   Cho, Eunyoung ^d   Rosner, Bernard ^d   Selhub, Jacob ^e   Fuchs, Charles S ^d,f   Meyerhardt, Jeffrey ^f   Giovannucci, Edward ^b,d  

^a Kyung Hee University   (South Korea)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c Sookmyung Women's University   (South Korea)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e TUFTS UNIVERSITY   (United States)

^f DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Colorectal cancer; Mortality; Prospective study; Pyridoxal 5 phosphate (PLP); Survival; Vitamin B6

Indexed keywords

CALCIFEDIOL; PYRIDOXINE;

ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER SURVIVAL; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; VITAMIN BLOOD LEVEL;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HEALTH PERSONNEL; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84876483783     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-013-0152-x     Document Type: Article

References (46)

1. American Cancer Society (2011) Cancer facts & figures 2011. American Cancer Society, Atlanta
2. Mehrkhani F, Nasiri S, Donboli K, Meysamie A, Hedayat A (2009) Prognostic factors in survival of colorectal cancer patients after surgery. Colorectal Dis 11:157-161
3. Vrieling A, Kampman E (2010) The role of body mass index, physical activity, and diet in colorectal cancer recurrence and survival: a review of the literature. Am J Clin Nutr 92:471-490
4. Chan AT, Giovannucci EL (2010) Primary prevention of colorectal cancer. Gastroenterology 138:2029-2043
5. Larsson SC, Orsini N, Wolk A (2010) Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA 303:1077-1083
6. 6 and plasma pyridoxal-P clearance: metabolic balance studies in humans. J Lab Clin Med 106:491-497
7. Selhub J (2002) Folate, vitamin B12 and vitamin B6 and one carbon metabolism. J Nutr Health Aging 6:39-42
8. Martial J, Zaldivar J, Bull P, Venegas A, Valenzuela P (1975) Inactivation of rat liver RNA polymerases I and II and yeast RNA polymerase I by pyridoxal 5′-phosphate. Evidence for the participation of lysyl residues at the active site. Biochemistry 14:4907-4911
9. Basu A, Tirumalai RS, Modak MJ (1989) Substrate binding in human immunodeficiency virus reverse transcriptase. An analysis of pyridoxal 5′-phosphate sensitivity and identification of lysine 263 in the substrate-binding domain. J Biol Chem 264:8746-8752
10. Diffley JF (1988) Affinity labeling the DNA polymerase a complex. I. Pyridoxal 5′-phosphate inhibition of DNA polymerase and DNA primase activities of the DNA polymerase a complex from Drosophila melanogaster embryos. J Biol Chem 263:14669-14677
11. Jain SK, Lim G (2001) Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na + + K +)-ATPase activity reduction in high glucose-treated human erythrocytes. Free Radic Biol Med 30:232-237
12. Komatsu S, Watanabe H, Oka T, Tsuge H, Kat N (2002) Dietary vitamin B6 suppresses colon tumorigenesis, 8-hydroxyguanosine, 4-hydroxynonenal, and inducible nitric oxide synthase protein in azoxymethane-treated mice. J Nutr Sci Vitaminol (Tokyo) 48:65-68
13. Roubenoff R, Roubenoff RA, Selhub J, Nadeau MR, Cannon JG, Freeman LM, Dinarello CA, Rosenberg IH (1995) Abnormal vitamin B6 status in rheumatoid cachexia. Association with spontaneous tumor necrosis factor alpha production and markers of inflammation. Arthr Rheum 38:105-109
14. Shen J, Lai CQ, Mattei J, Ordovas JM, Tucker KL (2010) Association of vitamin B-6 status with inflammation, oxidative stress, and chronic inflammatory conditions: the Boston Puerto Rican Health Study. Am J Clin Nutr 91:337-342
15. Komatsu SI, Watanabe H, Oka T, Tsuge H, Nii H, Kato N (2001) Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr 131:2204-2207
16. Matsubara K, Mori M, Matsuura Y, Kato N (2001) Pyridoxal 5′-phosphate and pyridoxal inhibit angiogenesis in serum-free rat aortic ring assay. Int J Mol Med 8:505-508
17. Matsubara K, Matsumoto H, Mizushina Y, Lee JS, Kato N (2003) Inhibitory effect of pyridoxal 5′-phosphate on endothelial cell proliferation, replicative DNA polymerase and DNA topoisomerase. Int J Mol Med 12:51-55
18. Belanger CF, Hennekens CH, Rosner B, Speizer FE (1978) The Nurses' Health Study. Am J Nurs 78:1039-1040
19. Colditz GA, Manson JE, Hankinson SE (1997) The Nurses' Health Study: 20-year contribution to the understanding of health among women. J Womens Health 6:49-62
20. Rich-Edwards JW, Corsano KA, Stampfer MJ (1994) Test of the National Death Index and Equifax Nationwide Death Search. Am J Epidemiol 140:1016-1019
21. Stampfer MJ, Willett WC, Speizer FE, Dysert DC, Lipnick R, Rosner B, Hennekens CH (1984) Test of the National Death Index. Am J Epidemiol 119:837-839
22. Sathiakumar N, Delzell E, Abdalla O (1998) Using the National Death Index to obtain underlying cause of death codes. J Occup Environ Med 40:808-813
23. Shin-Buehring YS, Rasshofer R, Endres W (1981) A new enzymatic method for pyridoxal-5-phosphate determination. J Inherit Metab Dis 4:123-124
24. Camp VM, Chipponi J, Faraj BA (1983) Radioenzymatic assay for direct measurement of plasma pyridoxal 5′-phosphate. Clin Chem 29:642-644
25. Ng K, Meyerhardt JA, Wu K, Feskanich D, Hollis BW, Giovannucci EL, Fuchs CS (2008) Circulating 25-hydroxyvitamin D levels and survival in patients with colorectal cancer. J Clin Oncol 26:2984-2991
26. Wolpin BM, Wei EK, Ng K, Meyerhardt JA, Chan JA, Selhub J, Giovannucci EL, Fuchs CS (2008) Prediagnostic plasma folate and the risk of death in patients with colorectal cancer. J Clin Oncol 26:3222-3228
27. Tamura T, Freeberg LE, Cornwell PE (1990) Inhibition of EDTA of growth of Lactobacillus casei in the folate microbiological assay and its reversal by added manganese or iron. Clin Chem 36:1993
28. Hollis BW (1997) Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers. Methods Enzymol 282:174-186
29. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase gene: an additional risk factor for neutral-tube defects? Am J Hum Genet 2:1044-1051
30. Lee JE, Wei EK, Fuchs CS, Hunter DJ, Lee IM, Selhub J, Stampfer MJ, Willett WC, Ma J, Giovannucci E (2012) Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control 23:537-545
31. Cox DR (1972) Regression models and life tables. J R Stat Soc 34:187-220
32. Durrleman S, Simon R (1989) Flexible regression models with cubic splines. Stat Med 8:551-561
33. Morris MS, Picciano MF, Jacques PF, Selhub J (2008) Plasma pyridoxal 5′-phosphate in the US population: the National Health and Nutrition Examination Survey, 2003-2004. Am J Clin Nutr 87:1446-1454
34. Hubner RA, Houlston RS (2007) MTHFR C677T and colorectal cancer risk: a metaanalysis of 25 populations. Int J Cancer 120:1027-1035
35. Lee JE, Li H, Giovannucci E, Lee IM, Selhub J, Stampfer M, Ma J (2009) Prospective study of plasma vitamin B6 and risk of colorectal cancer in men. Cancer Epidemiol Biomarkers Prev 18:1197-1202
36. Eussen SJ, Vollset SE, Hustad S, Midttun Ø, Meyer K, Fredriksen A, Ueland PM, Jenab M, Slimani N, Boffetta P, Overvad K, Thorlacius-Ussing O et al (2010) Plasma vitamins B2, B6, B12, and related genetic variants as predictors of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 19:2549-2561
37. Kim YI (2007) Folate and colorectal cancer: an evidence based critical review. Mol Nutr Food Res 51:267-292
38. Huang S, Parish EJ, Aull JL (1992) Irreversible inhibition of thymidylate synthase by pyridoxine (B6) analogues. J Enzyme Inhib Med Chem 6:149-156
39. Chen SC, Daron HH, Aull JL (1989) Inhibition of thymidylate synthase by pyridoxal phosphate. Int J Biochem 21:1217-1221
40. Chen J, Hunter DJ, Stampfer MJ, Kyte C, Chan W, Wetmur JG, Mosig R, Selhub J, Ma J (2003) Polymorphism in the thymidylate synthase promoter enhancer region modifies the risk and survival of colorectal cancer. Cancer Epidemiol Biomarkers Prev 12:958-962
41. Schernhammer ES, Giovannucci E, Kawasaki T, Rosner B, Fuchs CS, Ogino S (2010) Dietary folate, alcohol and B vitamins in relation to LINE-1 hypomethylation in colon cancer. Gut 59:794-799
42. Ogino S, Nosho K, Kirkner GJ, Kawasaki T, Chan AT, Schernhammer ES, Giovannucci EL, Fuchs CS (2008) A cohort study of tumoral LINE-1 hypomethylation and prognosis in colon cancer. J Natl Cancer Inst 100:1734-1738
43. Deeb KK, Trump DL, Johnson CS (2007) Vitamin D signaling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 7:684-700
44. Willett W (1998) Nutritional epidemiology, 2nd edn. Oxford University Press, New York
45. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE (1985) Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122:51-65
46. Wei EK, Giovannucci E, Selhub J, Fuchs CS, Hankinson SE, Ma J (2005) Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women. J Natl Cancer Inst 97:684-692